CHRONIC VENOUS DISEASE AND PSORIASIS - A RANDOM ASSOCIATION?

Authors

  • Raluca-Dana STAMATIN Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Laura GHEUCA-SOLOVASTRU Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Doinita TEMELIE-OLINICI Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Dumitrita GUGULUS Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Elena-Diana STANCIU Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Ana-Maria AROTARITEI Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Adriana PATRASCU Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • D. VATA Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

Aims: Chronic venous disease and psoriasis are two common pathologies in dermatological practice. The aim of this study is to determine the prevalence of venous disease among the psoriatic population and to identify risk factors that lead to their association. Materials and methods: This study included 375 patients diagnosed with psoriasis vulgaris, hospitalized in “Sf. Spiridon” County Clinical Emergency Hospital’s Dermatology-Venereology Clinic, between 01.01.2019 and 31.05.2021. Results: The prevalence of chronic venous disease in the study group was 37.3%, reaching the highest values ​​in the age group of 36-60 years (women: 40.7%, men: 48.6%, P = 0.040). Among the common risk factors, obesity had a prevalence of 19.2% and smoking 24.3% (P = <0.001). Among common comorbidities, hypertension had a prevalence of 47.1% and diabetes mellitus 13.6% (P = <0.001). Conclusions: In the future, more studies are required, in order to fully elucidate the mechanisms by which venous disease can be associated with psoriasis.

Author Biographies

  • Raluca-Dana STAMATIN, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    “Sf. Spiridon” County Clinical Emergency Hospital Iasi, Romania
    Department of Dermato-venereology

  • Laura GHEUCA-SOLOVASTRU, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    “Sf. Spiridon” County Clinical Emergency Hospital Iasi, Romania
    Department of Dermato-venereology

  • Doinita TEMELIE-OLINICI, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    “Sf. Spiridon” County Clinical Emergency Hospital Iasi, Romania
    Department of Dermato-venereology

  • Dumitrita GUGULUS, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    “Sf. Spiridon” County Clinical Emergency Hospital Iasi, Romania
    Department of Dermato-venereology

  • Elena-Diana STANCIU, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    “Sf. Spiridon” County Clinical Emergency Hospital Iasi, Romania
    Department of Dermato-venereology

  • Ana-Maria AROTARITEI, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    “Sf. Spiridon” County Clinical Emergency Hospital Iasi, Romania
    Department of Dermato-venereology

  • Adriana PATRASCU, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine

  • D. VATA, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine

References

1. Barrea L, Nappi F, Di Somma C, et al. Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist. Int J Environ Res Public Health 2016; 13(5): 743.
2. Petrescu Z, Țăranu T, Brănișteanu D, et al. Dermatologie și infecții transmise sexualǎ. Iasi: Ed Junimea, 2008.
3. Grajdeanu IA, Statescu L, Vata D, Popescu IA, Porumb-Andrese E, Solovastru Gheuca L. Imaging techniques in the diagnosis and monitoring of psoriasis. Exp Ther Med. 2019; 18(6): 4974-4980.
4. Ţolea I. Dermatovenerologie clinicǎ. Craiova: Editura Medicalǎ Universitarǎ, 2002.
5. Solovăstru Gheuca L, Vâţă D, Batog AH, et al. Comorbidities in psoriatic patients of Iasi Der-matological Clinic from 2004-2008. Med Surg J -Rev Med Chir Soc Med Nat, Iasi 2009; 113(3), 751-756.
6. Sundarrajan S, Arumugam M. Comorbidities of Psoriasis - Exploring the Links by Network Approach. PLoS One 2016; 11(3): e0149175.
7. Grechin C, Solovăstru Gheuca L, Vâță D, et al. Inflammatory marker alteration in response to systemic therapies in psoriasis. Experimental and Therapeutic Medicine 2020; 20: 42-46.
8. Spiridon M, Corduneanu D. Chronic Venous Insufficiency: Frequently Underdiagnosed and Undertreated Pathology. MAEDICA Journal of Clinical Medicine 2017; 12(1): 59-61.
9. Matthew Leach. Chronic venous insufficiency; In Basic medical Key 2015, chapter 11.
10. Davies HO, Popplewell M, Singhal R, Smith N, Bradbury AW. Obesity and lower limb venous disease - The epidemic of phlebesity. Phlebology: The Journal of Venous Disease 2016; 32(4): 227-233.
11. Cotter C, Walsh S. Cutaneous sequelae of a national health crisis: Obesity and the skin. Skin health and disease 2021, 1(1): e7.
12. Kim HN, Han K, Song SW, Lee JH. Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study. PLoS ONE 2018, 13.
13. Mahapatra S, Ramakrishna P, Gupta B, Anusha A, Para MA. Correlation of obesity & comorbid conditions with chronic venous insufficiency: Results of a single-center study. Indian J Med Res 2018; 147(5): 471-476.
14. Carman TL, Al-Omari A. Evaluation and Management of Chronic Venous Disease Using the Foundation of CEAP. Curr Cardiol Rep 2019: 21(10): 114.
15. Nuttall FQ. Body Mass Index: Obesity, BMI, and Health: A Critical Review. Nutr Today 2015; 50(3): 117-128.
16. Rotaru M. Psoriasis and associated cardiometabolic comorbidities. Acta Medica Transilvanica 2015; 20(1): 76-79.
17. Jendoubi F, Ben L, Rabhi F, et al. Nail Involvement in Psoriatic Patients and Association with Onychomycosis: Results from a Cross-Sectional Study Performed in a Military Hospital in Tunisia. Skin Appendage Disorders 2019; 5(5): 299-303.
18. Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk Factors for the Development of Psoriasis. Int J Mol Sci 2019; 20(18): 4347.
19. Stîncanu A, Andrese E, Stãtescu L, Vȃțǎ D, Solovastru Gheuca L. Leptin - a systemic inflammation marker in vulgar psoriasis associated with metabolic syndrome. Revista Societǎții Romane de Dermatologie 2014; 59; 209-216.
20. Vlajinac HD, Marinkovic, Maksimovic MZ, Matic PA, Radak DJ, Body Mass Index and Primary Chronic Venous Disease - A Cross-sectional Study. European Journal of Vascular and Endovascular Surgery 2013; 45(3): 293-298.
21. Jacobi A, Langenbruch A, Purwins S, Augustin M, Radtke MA. Prevalence of Obesity in Patients with Psoriasis: Results of the National Study PsoHealth3. Dermatology 2015; 231(3): 231-238.
22. Criqui MH, Denenberg JO, Langer RD, Fronek A. Risk factors for chronic venous disease: The San Diego Population Study. J Vasc Surg 2007; 46(2): 331-337.
23. Vuylsteke ME, Colman R, Bergan J, Langer RD, Fronek A. An Epidemiological Survey of Venous Disease Among General Practitioner Attendees in Different Geographical Regions on the Globe: The Final Results of the Vein Consult Program. Angiology 2018; 69(9): 779-785.
24. Gourgou S, Dedieu F, Sancho-Garnier H. Lower Limb Venous Insufficiency and Tobacco Smoking: A Case-Control Study, American Journal of Epidemiology 2002; 155(11): 1007-1015;
25. Adışen E, Uzun S, Erduran F, Gürer MA. Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis. An Bras Dermatol 2018; 93(2): 205-211.
26. Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and hypertension: A systematic review and meta-analysis of observational studies. J Hypertens 2013; 31: 433-442.
27. Puig L, Ferrándiz C, Pujol RM, et al. Burden of Psoriasis in Catalonia: Epidemiology, Associated Comorbidities, Health Care Utilization, and Sick Leave. Actas Dermosifiliogr (Engl Ed) 2021; 112(5): 425-433.

Additional Files

Published

2024-06-28

Issue

Section

INTERNAL MEDICINE - PEDIATRICS